Pityriasis Rosea Associated With COVID-19 Vaccination: A Common Rash Following Administration of a Novel Vaccine.

Authors

Brittany Valk, Beaumont Health Resident
Brett Bender, Beaumont Health

Document Type

Article

Publication Date

12-2021

Publication Title

Cutis

Abstract

Pityriasis rosea is a common, self-limited, papulosquamous eruption, classically presenting along the Langer lines of the skin. We report a clinically typical case of pityriasis rosea that developed following COVID-19 vaccination. As the novel COVID-19 vaccine becomes more widely available during the ongoing COVID-19 pandemic, it is imperative for both patients and clinicians to be aware of its association with the onset of this benign cutaneous eruption.

Volume

108

Issue

6

First Page

317

Last Page

318

Recommended Citation

Valk B, Bender B. Pityriasis Rosea Associated With COVID-19 Vaccination: A Common Rash Following Administration of a Novel Vaccine. Cutis. 2021 Dec;108(6):317-318. doi: 10.12788/cutis.0411. PMID: 35167784.

DOI

10.12788/cutis.0411

ISSN

2326-6929

PubMed ID

35167784